AI Health Awards: What 2026 Honors Reveal
A Fast Company award for AI health is more than PR. Learn how it validates your impact, attracts investors, and differentiates you from 200+ competitors.
Global Health Funding 2025: $48.9B vs $370B Need
Global health funding hit $48.9B, but falls short of needs. See why 60% of funds go to 10 countries and how to improve impact.
Deep Learning’s ECG Breakthrough: A VC’s Guide to Cardiac AI
The healthcare field is rapidly shifting, driven by AI innovations that promise to redefine early disease detection and intervention. While many headlines celebrate technological novelty,…
CFD & Deep Learning: AI’s Non-Invasive Cardiac Investment Frontier
The diagnostic field for coronary artery disease has long been fraught with a critical tension: the need for precise anatomical and functional assessment versus the…
VCs: De-Risking AI Diagnostics with Clinical Validation
The healthcare AI field is awash with dazzling technological claims, yet a critical chasm often separates novel algorithms from demonstrable clinical impact. For early-stage health…
Digital MSK: Where Reimbursement Value Truly Resides Post-Merger
The digital musculoskeletal (MSK) therapy field, once a frontier of nascent innovation, has matured into a highly competitive segment characterized by significant market consolidation. Investors…
AI’s Edge: Unlocking Novel Cancer Biomarkers for Early Detection
While the healthcare industry loves a shiny new technology, real innovation is measured by clinical impact. The AI Health Innovators Index gets this right, focusing…
Digital PT: Evidence-Driven Reimbursement for VCs
The digital health field is rife with technological promise, yet commercial viability often hinges not on the elegance of an algorithm, but on the rigor…
Algorithmic Bias: The Hidden Risk in Cardiac AI Investments
The hype around healthcare AI is hard to miss, with tools like Hello Heart getting “Most Innovative Companies” nods from Fast Company in 2026 for…
Digital Therapeutics for Insomnia: Clinical Validation for Investors
Software is starting to deliver clinical outcomes that, until now, you could only get from a pill. This shift is being driven by digital therapeutics,…